Lipid signaling in pathogenic fungi

Current Opinion in Microbiology

Volumn 9, Issue 4, 2006, Pages 352-358

  Shea, John M ^a   Del Poeta, Maurizio ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBASIDIN A; CYCLOHEXIMIDE; DIACYLGLYCEROL; ENZYME INHIBITOR; FARNESOL; FLUCONAZOLE; GALBONOLIDE A; ICOSANOID; KAFREFUNGIN; LIPID; NYSTATIN; SPHINGOLIPID; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC SENSITIVITY; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; BIOFILM; CANDIDA ALBICANS; CELL WALL; FUNGAL CELL; FUNGUS HYPHAE; GENE DISRUPTION; GENE EXPRESSION; MACROPHAGE; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENICITY; PHAGOCYTOSIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DIGLYCERIDES; EICOSANOIDS; FUNGI; HUMANS; SIGNAL TRANSDUCTION; SPHINGOLIPIDS;

ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; EMERICELLA NIDULANS; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 33746297857     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2006.06.003     Document Type: Review

References (42)

1. Takai Y., Kishimoto A., Kikkawa U., Mori T., and Nishizuka Y. Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system. Biochem Biophys Res Commun 91 (1979) 1218-1224
2. Becker K.P., and Hannun Y.A. Protein kinase C and phospholipase D: intimate interactions in intracellular signaling. Cell Mol Life Sci 62 (2005) 1448-1461
3. Kolesnick R. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110 (2002) 3-8
4. Oishi K., Raynor R.L., Charp P.A., and Kuo J.F. Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction. J Biol Chem 263 (1988) 6865-6871
5. Hannun Y.A., and Obeid L.M. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277 (2002) 25847-25850
6. Dickson R.C., and Lester R.L. Sphingolipid functions in Saccharomyces cerevisiae. Biochim Biophys Acta 1583 (2002) 13-25
7. Hanada K. Sphingolipids in infectious diseases. Jpn J Infect Dis 58 (2005) 131-148
8. Heung L.J., Luberto C., and Del Poeta M. Role of sphingolipids in microbial pathogenesis. Infect Immun 74 (2006) 28-39. A current and comprehensive review of the role sphingolipids play in mediating the interactions between host and pathogen during infection.
9. Noverr M.C., Erb-Downward J.R., and Huffnagle G.B. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev 16 (2003) 517-533
10. Sugimoto Y., Sakoh H., and Yamada K. IPC synthase as a useful target for antifungal drugs. Curr Drug Targets Infect Disord 4 (2004) 311-322
11. Luberto C., Toffaletti D.L., Wills E.A., Tucker S.C., Casadevall A., Perfect J.R., Hannun Y.A., and Del Poeta M. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev 15 (2001) 201-212
12. Luberto C., Martinez-Marino B., Taraskiewicz D., Bolanos B., Chitano P., Toffaletti D.L., Cox G.M., Perfect J.R., Hannun Y.A., Balish E., et al. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J Clin Invest 112 (2003) 1080-1094
13. Heung L.J., Luberto C., Plowden A., Hannun Y.A., and Del Poeta M. The sphingolipid pathway regulates Pkc1 through the formation of diacylglycerol in Cryptococcus neoformans. J Biol Chem 279 (2004) 21144-21153. This is the first study to show diacylglycerol activation of PKC in a fungal pathogen.
14. Ogita K., Miyamoto S., Koide H., Iwai T., Oka M., Ando K., Kishimoto A., Ikeda K., Fukami Y., and Nishizuka Y. Protein kinase C in Saccharomyces cerevisiae: comparison with the mammalian enzyme. Proc Natl Acad Sci USA 87 (1990) 5011-5015
15. Watanabe M., Chen C.Y., and Levin D.E. Saccharomyces cerevisiae PKC1 encodes a protein kinase C (PKC) homolog with a substrate specificity similar to that of mammalian PKC. J Biol Chem 269 (1994) 16829-16836
16. Schmitz H.P., and Heinisch J.J. Evolution, biochemistry and genetics of protein kinase C in fungi. Curr Genet 43 (2003) 245-254
17. Hurley J.H., Newton A.C., Parker P.J., Blumberg P.M., and Nishizuka Y. Taxonomy and function of C1 protein kinase C homology domains. Protein Sci 6 (1997) 477-480
18. Heung L.J., Kaiser A.E., Luberto C., and Del Poeta M. The role and mechanism of diacylglycerol-protein kinase C1 signaling in melanogenesis by Cryptococcus neoformans. J Biol Chem 280 (2005) 28547-28555. The diacylglycerol-binding C1 domain of Pkc1 mediates the effects of Ipc1-generated diacylglycerol on virulence factors such as melanization and capsule formation.
19. Gerik K.J., Donlin M.J., Soto C.E., Banks A.M., Banks I.R., Maligie M.A., Selitrennikoff C.P., and Lodge J.K. Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. Mol Microbiol 58 (2005) 393-408. A comprehensive study in which putative members of the Pkc1 signaling pathway in C. neoformans were identified and partially characterized.
20. Mare L., Iatta R., Montagna M.T., Luberto C., and Del Poeta M. APP1 transcription is regulated by IPC1-DAG pathway and is controlled by ATF2 transcription factor in Cryptococcus neoformans. J Biol Chem 280 (2005) 36055-36064. A new cryptococcal transcription factor, Atf2, was found to induce the transcription of the virulence factor App1 in the presence of increased diacylglycerol.
21. Hornby J.M., Jensen E.C., Lisec A.D., Tasto J.J., Jahnke B., Shoemaker R., Dussault P., and Nickerson K.W. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 67 (2001) 2982-2992
22. Oh K.B., Miyazawa H., Naito T., and Matsuoka H. Purification and characterization of an autoregulatory substance capable of regulating the morphological transition in Candida albicans. Proc Natl Acad Sci USA 98 (2001) 4664-4668
23. Navarathna D.H., Hornby J.M., Hoerrmann N., Parkhurst A.M., Duhamel G.E., and Nickerson K.W. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. J Antimicrob Chemother 56 (2005) 1156-1159. One of the first studies to indirectly address the role of farnesol in a murine model of infection. Azole-exposed C. albicans produced higher amounts of farnesol and were hypervirulent in mice.
24. Mosel D.D., Dumitru R., Hornby J.M., Atkin A.L., and Nickerson K.W. Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum. Appl Environ Microbiol 71 (2005) 4938-4940. This study systemically characterized the concentrations of farnesol needed to block hyphal formation under a number of inducing conditions. The authors provide evidence that lipid-binding albumin in serum might play a significant role in attenuating the effects of farnesol.
25. Enjalbert B., and Whiteway M. Release from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growth. Eukaryot Cell 4 (2005) 1203-1210
26. Cao Y.Y., Cao Y.B., Xu Z., Ying K., Li Y., Xie Y., Zhu Z.Y., Chen W.S., and Jiang Y.Y. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother 49 (2005) 584-589
27. Chen J., Zhou S., Wang Q., Chen X., Pan T., and Liu H. Crk1, a novel Cdc2-related protein kinase, is required for hyphal development and virulence in Candida albicans. Mol Cell Biol 20 (2000) 8696-8708
28. Zheng X., Wang Y., and Wang Y. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J 23 (2004) 1845-1856
29. Kruppa M., Krom B.P., Chauhan N., Bambach A.V., Cihlar R.L., and Calderone R.A. The two-component signal transduction protein Chk1p regulates quorum sensing in Candida albicans. Eukaryot Cell 3 (2004) 1062-1065
30. Semighini C.P., Hornby J.M., Dumitru R., Nickerson K.W., and Harris S.D. Farnesol-induced apoptosis in Aspergillus nidulans reveals a possible mechanism for antagonistic interactions between fungi. Mol Microbiol 59 (2006) 753-764. A. nidulans exposed to physiological concentrations of farnesol undergoes an apoptotic-like death. This study unveiled a novel role for farnesol as an antifungal agent.
31. Shchepin R., Dumitru R., Nickerson K.W., Lund M., and Dussault P.H. Biologically active fluorescent farnesol analogs. Chem Biol 12 (2005) 639-641
32. Hornby J.M., Kebaara B.W., and Nickerson K.W. Farnesol biosynthesis in Candida albicans: cellular response to sterol inhibition by zaragozic acid B. Antimicrob Agents Chemother 47 (2003) 2366-2369
33. Hornby J.M., and Nickerson K.W. Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob Agents Chemother 48 (2004) 2305-2307
34. Ong T.P., Heidor R., de Conti A., Dagli M.L., and Moreno F.S. Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis (2005)
35. Pasrija R., Prasad T., and Prasad R. Membrane raft lipid constituents affect drug susceptibilities of Candida albicans. Biochem Soc Trans 33 (2005) 1219-1223. Ergosterol and complex sphingolipid synthesis were found to be necessary to develop drug resistance in C. albicans. This might be as a result of the formation of lipid microdomains which stabilize the membrane drug efflux pump Cdr1p.
36. Machida K., Tanaka T., Yano Y., Otani S., and Taniguchi M. Farnesol-induced growth inhibition in Saccharomyces cerevisiae by a cell cycle mechanism. Microbiol 145 (1999) 293-299
37. Westwater C., Balish E., and Schofield D.A. Candida albicans-conditioned medium protects yeast cells from oxidative stress: a possible link between quorum sensing and oxidative stress resistance. Eukaryot Cell 4 (2005) 1654-1661. The link between farnesol and resistance to oxidative stress is established. This study also partially characterizes another secreted molecule in cultures that is able to induce the transcription of oxidative stress-protective genes.
38. Noverr M.C., Phare S.M., Toews G.B., Coffey M.J., and Huffnagle G.B. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun 69 (2001) 2957-2963
39. Alem M.A., and Douglas L.J. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 54 (2005) 1001-1005
40. Noverr M.C., Toews G.B., and Huffnagle G.B. Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun 70 (2002) 400-402
41. Tsitsigiannis D.I., Kowieski T.M., Zarnowski R., and Keller N.P. Three putative oxylipin biosynthetic genes integrate sexual and asexual development in Aspergillus nidulans. Microbiol 151 (2005) 1809-1821
42. Tsitsigiannis D.I., Bok J.W., Andes D., Nielsen K.F., Frisvad J.C., and Keller N.P. Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence. Infect Immun 73 (2005) 4548-4559. The first enzymes involved in eicosanoid production in pathogenic fungi are identified. Suppressing the expression of these enzymes results in a hypervirulent strain.